1.
Efficacy Of Loralatinib In Combination With Alectinib In Patients With Anaplastic Kinase-Positive Small Cell Lung Cancer With Moderate Lung Disease: A Case Report. Clinical and Medical Case Reports. 2022;2(01):34-37. Accessed January 22, 2025. https://currentopinion.info/index.php/cmcr/article/view/77